2024年10月10日 · Studies over the past decade have suggested that treatment via pluripotent stem cells —a type of unspecialized cell that can develop into other types of cells—could lead to a cure, per the...

1 天前 · The insulin cells are killed by an autoimmune process in type 1 diabetes, which affects roughly nine million people worldwide. Although islet transplantation is a promising approach for treating such cases, the only FDA-approved method to date has significant limitations.

Lantidra is approved for the treatment of adults with type 1 diabetes who are unable to approach target glycated hemoglobin (average blood glucose levels) because of current repeated episodes of...

2024年12月10日 · For more than 15 years, researchers at the Icahn School of Medicine at Mount Sinai have worked tirelessly to find a solution to cure diabetes by identifying a drug that could make human beta cells regenerate.

2024年10月29日 · Even with potential barriers ahead, the early results of the clinical trial do offer hope for a future cure for Type 1 diabetes that is already helping people like Gilada and Goedel live better lives.

2025年1月15日 · A first-in-human study of Sana Biotechnology’s transplanted islet cells has shown potential as a possible treatment for type 1 diabetes, enabling an enrolled patients to avoid immune rejection and produce insulin.

2023年7月13日 · The FDA has approved a new drug called Lantidra to manage low blood sugar in people with type 1 diabetes. The drug helps control blood sugar levels through an infusion of donor pancreatic cells that create insulin in the body so that patients no longer need to take external insulin.

2024年9月26日 · In type 1 diabetes, the immune system attacks islet cells in the pancreas. Islet transplants can treat the disease, but there aren’t enough donors to meet the growing demand, and recipients...

2022年4月14日 · No cure for type 1 diabetes currently exists, but promising research is ongoing. Read on to learn more about how doctors and scientists are working toward a cure for type 1 diabetes.

2021年10月20日 · Utilizing research from the Melton Lab, Vertex Pharmaceuticals has developed VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes (T1D).